Early magnesium modifications as a surrogate marker of efficacy of cetuximab-based anticancer treatment in KRAS wild-type advanced colorectal cancer patients
Titel:
Early magnesium modifications as a surrogate marker of efficacy of cetuximab-based anticancer treatment in KRAS wild-type advanced colorectal cancer patients
Auteur:
Vincenzi, B. Galluzzo, S. Santini, D. Rocci, L. Loupakis, F. Correale, P. Addeo, R. Zoccoli, A. Napolitano, A. Graziano, F. Ruzzo, A. Falcone, A. Francini, G. Dicuonzo, G. Tonini, G.